WC
PFE icon

Whitnell & Co’s Pfizer PFE Stock Holding History

Whitnell & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2M Buy
53,841
+607
+1% +$21.6K 0.61% 51
2019
Q3 		$1.81M Buy
53,234
+42,370
+390% +$1.54M 0.61% 53
2019
Q2 		$446K Buy
10,864
+1
+0% +$40 0.17% 99
2019
Q1 		$438K Buy
10,863
+2
+0% +$80 0.17% 99
2018
Q4 		$450K Sell
10,861
-694
-6% -$28.8K 0.2% 97
2018
Q3 		$483K Buy
11,555
+1
+0% +$38 0.19% 94
2018
Q2 		$398K Sell
11,554
-663
-5% -$22.7K 0.17% 101
2018
Q1 		$411K Buy
12,217
+1,250
+11% +$43K 0.17% 99
2017
Q4 		$377K Buy
10,967
+1
+0% +$34 0.16% 105
2017
Q3 		$371K Buy
10,966
+1
+0% +$32 0.16% 102
2017
Q2 		$349K Buy
10,965
+1
+0% +$32 0.15% 107
2017
Q1 		$356K Buy
10,964
+169
+2% +$5.33K 0.16% 107
2016
Q4 		$333K Sell
10,795
-1,838,772
-99% -$56.1M 0.15% 108
2016
Q3 		$59.4M Buy
1,849,567
+1
+0% +$33 20.29% 1
2016
Q2 		$61.8M Buy
1,849,566
+713,731
+63% +$22.8M 20.14% 1
2016
Q1 		$31.9M Buy
1,135,835
+36,393
+3% +$1.04M 11.88% 1
2015
Q4 		$33.7M Hold
1,099,442
– – 12.7% 1
2015
Q3 		$32.8M Hold
1,099,442
– – 12.9% 1
2015
Q2 		$35M Sell
1,099,442
-1,305
-0.1% -$42.5K 12.67% 1
2015
Q1 		$36.3M Sell
1,100,747
-9,486
-0.9% -$302K 13.6% 1
2014
Q4 		$32.8M Hold
1,110,233
– – 12.35% 1
2014
Q3 		$31.1M Buy
1,110,233
+694,213
+167% +$19.5M 12.42% 1
2014
Q2 		$11.7M Sell
416,020
-65
-0% -$1.85K 5.35% 2
2014
Q1 		$12.7M Sell
416,085
-3,162
-0.8% -$94.3K 5.95% 1
2013
Q4 		$12.2M Sell
419,247
-1,054
-0.3% -$30.7K 5.59% 1
2013
Q3 		$11.5M Sell
420,301
-2,907
-0.7% -$79.1K 5.64% 1
2013
Q2 		$11.2M Buy
+423,208
New +$11.7M 5.6% 1

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Whitnell & Co's PFE Position: Q4 2019 in Review

Whitnell & Co increased its Pfizer (PFE) stake by 1.1% in Q4 2019, buying an estimated $21.6K and bringing the position to 53,841 shares worth $2M. The position accounts for 0.61% of the portfolio, ranked #51.

Whitnell & Co first reported a position in PFE in Q2 2013 and has held it in 27 quarters since. The position peaked at $61.8M in Q2 2016. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • Whitnell & Co held 53,841 shares of Pfizer worth $2M as of Q4 2019.
  • Whitnell & Co bought 607 Pfizer shares in Q4 2019, an estimated $21.6K.
  • Pfizer made up 0.61% of Whitnell & Co's portfolio in Q4 2019, its #51 holding.
  • Whitnell & Co first reported a position in Pfizer in Q2 2013 and has held it in 27 quarters since.
  • Whitnell & Co's Pfizer position peaked at $61.8M in Q2 2016.
  • 2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.